Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Latest in our Congress Watch

Small Cell Lung Cancer

Liposomal Irinotecan Fails To Extend Advanced SCLC Survival

From ELCC 2023:
Liposomal irinotecan does not offer significantly better overall survival than topotecan for patients with small-cell lung cancer that has progressed during or after first-line platinum-based chemotherapy 

E-learning general banner

ESMO E-Learning

Our E-Learning webcasts are produced by leading experts in oncology and include a CME test. ESMO Members can access numerous Modules covering all areas of oncology.

Explore the library
ESMO-Guidelines-Block-1000x333px

ESMO Guidelines

Supporting your clinical decisions with ESMO’s regularly updated Clinical Practice Guidelines and consensus recommendations, developed by the leading experts in our profession.

Discover more
Past ESMO Preceptorships

Courses slides & webcasts

Organised by topic, all slides and webcasts are available to ESMO Members.
Check the latest courses published on NSCLC, IO, Breast, Gastric Cancers and precision medicine (KRAS, EGFR, NTRK).

Access courses by topic

Latest in our Congress Watch

Join ESMO today for full access to all OncologyPRO Content

 
Some of the content presented is exclusively for ESMO members - Join today to access all of ESMO’s educational and scientific resources on OncologyPRO.

Become a member

Scientific resources from ESMO meetings

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.